Comparative Cardioprotective Effects of SGLT2 Inhibitors in Preclinical Models of Diabetic Cardiomyopathy. VER [Internet]. 2025 Dec. 14 [cited 2026 Jun. 28];8(20s):1-9. Available from: https://verjournal.com/index.php/ver/article/view/1471